115 related articles for article (PubMed ID: 38685721)
1. Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
Suraju MO; Freischlag K; McKeen A; Nayyar A; Thompson D; Gordon DM; Mishra A; Sherman SK; Goffredo P; Hassan I
J Surg Oncol; 2024 Apr; ():. PubMed ID: 38685721
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
Mao R; Li K; Cai JQ; Luo S; Turner M; Blazer D; Zhao H
Ann Surg; 2021 Aug; 274(2):e126-e133. PubMed ID: 31478977
[TBL] [Abstract][Full Text] [Related]
4. Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma.
Wang Q; Yin R; Tang W; Li C; Zheng H; Zhang X; Jin X; Ying M; Fu J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):594-602. PubMed ID: 36581574
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.
Osagiede O; Habermann E; Day C; Gabriel E; Merchea A; Lemini R; Jabbal IS; Colibaseanu DT
J Gastrointest Oncol; 2020 Oct; 11(5):836-846. PubMed ID: 33209480
[TBL] [Abstract][Full Text] [Related]
6. Redefining High-Volume Gastric Cancer Centers: The Impact of Operative Volume on Surgical Outcomes.
Ju MR; Blackwell JM; Zeh HJ; Yopp AC; Wang SC; Porembka MR
Ann Surg Oncol; 2021 Sep; 28(9):4839-4847. PubMed ID: 33566249
[TBL] [Abstract][Full Text] [Related]
7. Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
Fields AC; Lu P; Vierra BM; Hu F; Irani J; Bleday R; Goldberg JE; Nash GM; Melnitchouk N
Ann Surg Oncol; 2019 Apr; 26(4):1127-1133. PubMed ID: 30706232
[TBL] [Abstract][Full Text] [Related]
8. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and survival outcomes of colorectal mixed neuroendocrine-non-neuroendocrine neoplasms and neuroendocrine carcinoma.
Suraju MO; Freischlag K; Jacob D; Thompson D; Mckeen A; Tran C; Sherman SK; Goffredo P; Weigel RJ; Hassan I
Surgery; 2024 Mar; 175(3):735-742. PubMed ID: 37867105
[TBL] [Abstract][Full Text] [Related]
10. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
11. Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma.
Chen D; Bao X; Zhang R; Ding Y; Zhang M; Li B; Zhang H; Li X; Tong Z; Liu L; Zhou X; Wang S; Cheng X; Zheng Y; Ruan J; Fang W; Zhao P
Br J Cancer; 2021 Sep; 125(7):994-1002. PubMed ID: 34331023
[TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy With or Without Surgery for Esophageal Squamous Cancer According to Hospital Volume.
Duarte MBO; Pereira EB; Lopes LR; Andreollo NA; Carvalheira JBC
JCO Glob Oncol; 2020 Jun; 6():828-836. PubMed ID: 32552112
[TBL] [Abstract][Full Text] [Related]
13. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Center Esophagectomy Volume on Outcomes in Clinical Stage I to III Esophageal Cancer.
Rhodin KE; Raman V; Jensen CW; Kang L; Harpole DH; D'Amico TA; Tong BC
Ann Surg; 2023 Jul; 278(1):79-86. PubMed ID: 36040026
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
16. Defining Volume Targets for Regionalization of Pancreaticoduodenectomy, Esophagectomy, and Major Lung Resection Centers to Improve Oncologic and Surgical Outcomes.
Ju MR; Karalis JD; Leonard G; Mansour JC; Karagkounis G; Wang SC; Reznik SI; Porembka MR
Ann Surg Oncol; 2024 Jan; 31(1):499-513. PubMed ID: 37755565
[TBL] [Abstract][Full Text] [Related]
17. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base.
Liu C; Rein L; Clarke C; Mogal H; Tsai S; Christians KK; Gamblin TC
J Surg Oncol; 2020 Aug; 122(2):176-182. PubMed ID: 32383268
[TBL] [Abstract][Full Text] [Related]
18. Care at high-volume centers is associated with improved outcomes for patients with pancreatic neuroendocrine tumors: A population-level analysis.
Patel RK; Sutton TL; Schwantes IR; Behrens S; Pommier RF; Rocha FG; Sheppard BC
J Surg Oncol; 2023 May; 127(6):956-965. PubMed ID: 36905335
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a prognostic nomogram for patients with colorectal neuroendocrine carcinoma.
Zhuang Y; Yu H; Chen CJ; Jian JL; Wu XY
Asian J Surg; 2024 Jan; 47(1):433-442. PubMed ID: 37778975
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for a Large Cohort of Patients with Rectal Neuroendocrine Tumors: an Analysis of the National Cancer Database.
Zhao B; Hollandsworth HM; Lopez NE; Parry LA; Abbadessa B; Cosman BC; Ramamoorthy SL; Eisenstein S
J Gastrointest Surg; 2021 Feb; 25(2):484-491. PubMed ID: 32016672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
